Industry News
Chemeq raises $8m
Chemeq has raised $8 million in its latest placement to institutions and other sophisticated investors, bringing the total raised this year to $15.5 million. [ + ]
Skin surface laser patent granted to Norwood
Drug delivery group Norwood Abbey has added another patent to its portfolio, the latest covering laser technology to alter the skin's surface. [ + ]
Cell death key discovered by Monash Institute
Melbourne researchers have uncovered a new genetic player in programmed cell death, offering a fresh target for potential cancer therapies. [ + ]
Euro decision disappoints Stem Cell Sciences
A decision by the European Patent Office (EPO) to revise the controversial 'Edinburgh' patent to exclude embryonic stem cells has disappointed Australian company Stem Cell Sciences. [ + ]
Mayne backs new brain centre
A new Sydney imaging centre is set to improve research opportunities for brain and nervous system specialists. [ + ]
Discovery raises hopes for bone disease sufferers
Monash University researchers have identified two basic mechanisms that control the level of calcium deposition in bones and joints, a finding that could lead to treatments for osteoporosis and some forms of arthritis.
[ + ]IT awards seeking bio-IT involvement
Bio-IT innovators are being encouraged to enter this year's Asia-Pacific Australian Information Communication and Technology (ICT) Awards. [ + ]
EQiTX, Starphama appoint heavy hitters
Born-again oil exploration company EQiTX has added another science heavyweight to its ranks for its latest incarnation as a biotech. [ + ]
Optiscan appoints new chairman
A new chairman with science and manufacturing experience is to head the board of Optiscan. [ + ]
Aventis CropScience becomes Bayer CropScience
Aventis CropScience has officially become Bayer CropScience as a result of last year's acquisition of the CropScience unit by Bayer for around 7.25 billion euros ($AU13.4 billion). [ + ]
Monash researchers in osteoporosis find
An international collaboration including Melbourne researchers has uncovered two reasons for calcium deposits in bones and joints, setting the foundation for new osteoporosis therapies. [ + ]
Gradipore's Texan work nears completion
Sydney bioseparations specialist Gradipore has revealed that the first stage of its collaborative work with Texas A&M University is nearing completion. [ + ]
Innovation patent system gets a workout
Patent attorneys will be watching closely this week as the legal status of the Federal Government's innovation patents system is tested for the first time in court. [ + ]
Cutler joins CSIRO board
Former Industry, Research and Development Board chairman Dr Terry Cutler has been named as the fourth new appointee to the CSIRO board in the last two months. [ + ]
Starpharma gains new US patent approval
Nanotechnology drug developer Starpharma Pooled Development today announced it had gained approval for a United States patent over its dendrimer-based anti-cancer products. [ + ]
